Antimalarial Drug Market Growing Popularity And Emerging Trends As A Effective To Reduce COVID 19 Symptoms
Apr 07, 2020: The global Antimalarial Drug market was valued at $XX million in 2017, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. Indian and worldwide pharma companies stepped up the production of Hydroxychloroquine sulfate Antimalarial medicines which shows the effectiveness against the coronavirus by the recent study result by International Journal of Antimicrobial Agents. This drugs reduce the symptoms of virus by huge margin, it is tested on the patients in France and China. In China they mostly used chloroquine for treatment. Companies like Teva, Mylan, Amneal are ready to distribute the HCQs drugs which is mostly used for the malaria, rheumatoid arthritis and lupus. Recent news shows shortage of HCQS in USA, India Lifted the export ban of HCQS to the countries which are mostly affected by coronavirus (COVID 19). Latest trial conducted in France C...